The review argues that inflammatory contexts create local metabolic stress (including nutrient depletion, reactive oxygen/nitrogen species, and oxygen tension shifts) that can engage hypoxia-inducible factor (HIF) signaling in the intestinal epithelium, promoting barrier function and restitution programs.
A key cited functional support is epithelial HIF-1α requirement in murine colitis: epithelial loss of HIF-1a leads to more severe colitic phenotypes including increased permeability, while constitutive epithelial HIF activity is reported as protective (with the review explicitly noting model dependence and that HIF can also promote inflammation in other settings).
The review further emphasizes that HIF-driven barrier-protective pathways are not limited to classic tight-junction structural proteins (claudins/occludin), but also include broader integrity functions such as mucin biology and nucleotide metabolism programs.
The review’s central architectural claim is that extracellular adenine nucleotides are rapidly metabolized by ecto-enzymes CD39 and CD73, converting ATP/ADP → AMP → adenosine, and that this adenosine signaling promotes epithelial barrier restitution.
A specific mechanistic link used by the review is that inhibition of CD73 with APCP or anti-CD73 can inhibit resealing of endothelial/epithelial barriers by up to ~85%, supporting necessity for extracellular nucleotide metabolism in this pathway.
It also summarizes an adenosine mechanism of junction regulation via adenosine A2B receptor signaling leading to intracellular cAMP elevation, cytoskeletal rearrangements, and tight junction resealing, including discussion of VASP localization/phosphorylation at the junction following adenosine analog stimulation.
Skeptical boundary: the review repeatedly draws mechanistic conclusions from in vitro or model-system studies that may not fully preserve in vivo architecture (cell heterogeneity, oxygen gradients, mucus, microbiota, shear forces). This is not an internal fault of the review—this is intrinsic to the translational problem: the review acknowledges that protective vs pro-inflammatory HIF effects can be context-dependent.
The review argues that epithelial restitution after insult is energy demanding because tight-junction dynamics require ATP-dependent cytoskeletal remodeling (e.g., actin/myosin-related processes), and it positions creatine kinase (CK) and phosphocreatine (PCr) as a buffering system that helps maintain ATP phosphorylation potential for barrier function during inflammation.
What’s solid vs uncertain: solid—CK/PCr buffering is a well-established energy system in other tissues; the review claims epithelial junction localization and HIF control, but the degree to which creatine metabolism is necessary/sufficient for restitution vs merely correlated with energetic state is not fully resolved by review-level evidence.
The review presents PHD inhibition as a strategy to stabilize HIF-α and induce downstream barrier-protective programs, summarizing preclinical colitis model benefits including improved symptoms/markers and epithelial HIF-1α dependence in at least one cited scheme.
Skeptical boundary: as a narrative review, translational “therapeutic” conclusions depend on how preclinical effects were measured and whether models adequately match human IBD heterogeneity (timing, disease stage, microbiota, comorbidities). The review flags that some findings are model dependent and context dependent.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.